Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 0115-1526

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 0115-1526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lamotrigine Orally Disintegrating Tablets 1)

Chemical structure diagram of Lamotrigine, showing its chlorinated phenyl ring and triazine ring with amino groups.*

FDA Label Image

Figure 1 Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 1) (Lamotrigine Orally Disintegrating Tablets 2)

A Kaplan-Meier failure probability curve comparing lamotrigine and placebo over a span of approximately 100 weeks. The y-axis shows failure probability percentage from 0% to 100%, and the x-axis represents time in weeks. The graph includes censored data points for both groups, with lamotrigine showing a lower failure probability over time relative to placebo.*

FDA Label Image

Figure 2 Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Mood Episode (trial 2) (Lamotrigine Orally Disintegrating Tablets 3)

A Kaplan-Meier survival curve graph showing failure probability (%) on the y-axis and time in weeks on the x-axis. The graph compares two groups: Placebo and Lamotrigine, illustrating their respective failure probabilities over approximately 80 weeks. Censored data points are marked on the curves.*

FDA Label Image

Lamotrigine Orally Disintegrating Tablets (Lamotrigine Orally Disintegrating Tablets 4)

Illustration showing Lamotrigine orally disintegrating tablets in four strengths: 25 mg, 50 mg, 100 mg, and 200 mg. Each tablet is off-white to white with 'WPI' debossed on one side and the corresponding strength code (3721, 3722, 3723, 3724) on the other side.*

FDA Label Image

Principal Display Panel (25 mg Tablet Blister Pack Carton)

Lamotrigine 25 mg orally disintegrating tablets packaging label showing a carton that holds 30 tablets in 2 blisters of 15 tablets each. The label indicates it is a prescription-only drug distributed by Impax, manufactured by Watson Pharma Private Ltd in India. The label includes usage cautions, storage instructions, and phenylalanine content information.*

FDA Label Image

Principal Display Panel (50 mg Tablet Blister Pack Carton)

Lamotrigine 50 mg orally disintegrating tablets packaging label from Amneal Pharmaceuticals of New York LLC. The label indicates a count of 30 tablets divided into 2 blisters of 15 tablets each. The design includes usage caution, storage instructions, and manufacturer details. The label also highlights phenylalanine content for phenylketonurics and shows the product is Rx only.*

FDA Label Image

Principal Display Panel (100 mg Tablet Blister Pack Carton)

Lamotrigine 100 mg orally disintegrating tablets carton packaging label from Amneal Pharmaceuticals of New York LLC. The label indicates a package of 30 tablets, divided into 3 blisters with 10 tablets each. The front panel prominently displays the strength, dosage form, and quantities. Additional caution and storage instructions are visible, along with distributor and manufacturer details.*

FDA Label Image

Principal Display Panel (200 mg Tablet Blister Pack Carton)

Lamotrigine 200 mg orally disintegrating tablets packaging label by Amneal Pharmaceuticals of New York LLC shows a box containing 30 tablets in 3 blisters of 10 tablets each. The label includes warnings, storage instructions, and notes for phenylketonurics. It also indicates the product is for prescription use only (Rx only) and is distributed by Impax Generics.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.